Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Review: dendritic cell immunotherapy for melanoma.

Cancer biotherapy & radiopharmaceuticals - 1 Feb 1999

Hadzantonis M, O'Neill H

Abstract excerpt

Melanoma is a particularly aggressive malignant tumour of the skin that is influenced by genetic, environmental and physiological elements. Since current therapy for melanoma is limited and associated with high toxicity and side effects, development of alternative approaches is imperative. The importance of dendritic cells (DCs) in immunity against tumours is now well established. DC immunotherapy for melanoma is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adjuvants, Immunologic
Share to Antigen Presentation
Share to Cancer Vaccines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunodominant Epitopes

Share to Immunotherapy, Adoptive

Share to Melanoma, Experimental

Share to Neoplasms, Radiation-Induced

Share to Vaccines, DNA

Source

Identifiers

PMID: 10850282
DOI: 10.1089/cbr.1999.14.11

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Review: dendritic cell immunotherapy for melanoma.PMID 10850282Read ↗

Dendritic cell vaccines in melanoma: from promise to proof?Semantic proximity Read ↗

Dendritic cell therapy for skin cancer.Semantic proximity Read ↗

Cellular Immunotherapy with Dendritic Cells in Cancer: Current StatusSemantic proximity Read ↗

A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injectionSemantic proximity Read ↗

Dendritic Cells and Their Role in Immunotherapy.Semantic proximity Read ↗

New approaches to the development of adenoviral dendritic cell vaccines in melanoma.Semantic proximity Read ↗

Development of Cell Technologies Based on Dendritic Cells for Immunotherapy of Oncological DiseasesSemantic proximity Read ↗

Overview of melanoma vaccines and promising approaches.Semantic proximity Read ↗

Dendritic cells in cancer immunotherapySemantic proximity Read ↗

Active immunization against cancer with dendritic cells: the near future.Semantic proximity Read ↗

Dendritic Cells Loaded With mRNA Encoding Full-length Tumor Antigens Prime CD4+ and CD8+ T Cells in Melanoma PatientsSemantic proximity Read ↗

Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.